GLP-1R Agonists and Weight Loss The weight loss impacts of GLP-1 receptor agonists likely arise from several physiological effects (1)
Most common side effects are nausea, vomiting, constipation, and diarrhea, typically mild and temporary during the dose escalation phase
Although GLP-1s are a promising intervention for reducing multiple chronic conditions, it is important that future research focuses, too, on psychosocial health, especially in perimenopausal women who have greater utilization of GLP-1s and greater risk for adverse changes in physiological and psychosocial health relative to men and to younger and older women
People assume that overweight people are lazy or gluttonous
If reactions persist beyond 3-4 days or progressively worsen despite conservative management, medical evaluation is warranted